Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project

Alessandro Lagana, PhD, David Melnekoff, BS, MSc, Itai Beno, PhD, Violetta Leshchenko, PhD, Deepak Perumal, PhD, Jonathan J. Keats, PhD, Mary DeRome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2017) 130 (Supplement 1): 325.

https://doi.org/10.1182/blood.V130.Suppl_1.325.325

Published: 2017

Journal Articles

Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma

Alessandro Lagana, PhD, Violetta Leshchenko, PhD, David Melnekoff, BS, MSc, Itai Beno, PhD, Deepak Perumal, PhD, Jonathan Keats, PhD, Mary DeRome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2017) 130 (Supplement 1): 268.

https://doi.org/10.1182/blood.V130.Suppl_1.268.268

Published: 2017

Journal Articles

Aberrant a-to-I RNA Editing and Prognostic Impact of Adar in Multiple Myeloma Patients with 1q Amplification

Alessandro Lagana, PhD, Deepak Perumal, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Brian Kidd, PhD, Jonathan J Keats, PhD, Mary Derome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 357.

https://doi.org/10.1182/blood.V128.22.357.357

Published: 2016

Journal Articles

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Blood (2016) 128 (22): 194.

https://doi.org/10.1182/blood.V128.22.194.194

Published: 2016

Journal Articles

Prognostic Implication of Somatic Mutations By Next Generation Sequencing: An Analysis from the Mmrf Commpass Study in Newly Diagnosed Multiple Myeloma Patients

Blood (2016) 128 (22): 2079.

https://doi.org/10.1182/blood.V128.22.2079.2079

Published: 2016

Journal Articles

Bayesian Network Models of Multiple Myeloma: Drivers of High Risk and Durable Response

Fred Gruber, PhD, Jonathan J Keats, PhD, Kyle McBride, MS, Karl Runge, PhD, Diane Wuest, Tiffany Hadzi, Mary Derome, MS, Sagar Lonial, MD FACP, Iya Khalil, PhD, Boris Hayete, Daniel Auclair, PhD

Blood (2016) 128 (22): 4406.

https://doi.org/10.1182/blood.V128.22.4406.4406

Published: 2016

Journal Articles

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

Alessandro Lagana, PhD, Deepak Perumal, PhD, David Melnekoff, BS, Ben Readhead, MBBS, Brian Kidd, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Jonathan J Keats, PhD, Mary Derome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 3285.

https://doi.org/10.1182/blood.V128.22.3285.3285

Published: 2016

Journal Articles

A Comparison of Clinical FISH and Sequencing Based FISH Estimates in Multiple Myeloma: An Mmrf Commpass Analysis

Chase Miller, BSc, Jennifer Yesil, MS, Mary Derome, MS, Andrea Donnelly, Jean Marrian, Kyle McBride, MS, Mmrf CoMMpass Network, Daniel Auclair, PhD, Jonathan J Keats, PhD

Blood (2016) 128 (22): 374.

https://doi.org/10.1182/blood.V128.22.374.374

Published: 2016

Journal Articles

Network Modeling Reveals CDC42BPA and CLEC11A As Novel Driver Genes of t(4; 14) Multiple Myeloma

Deepak Perumal, PhD, Alessandro Lagana', PhD, David Melnekoff, BS, Ben Readhead, MBBS, Brian Kidd, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Jennifer Yesil, MS, Mary Derome, MS, Daniel Auclair, PhD, Deepu Madduri, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 802.

https://doi.org/10.1182/blood.V128.22.802.802

Published: 2016

Journal Articles

In-Depth Molecular Profiling of Multiple Myeloma in African Americans

Zarko Manojlovic, PhD, Austin Christofferson, Christophe Legendre, PhD, Gill Spreyer, PhD, Seungchan Kim, PhD, Winnie Liang, PhD, George Mulligan, PhD, Pamela G. Kidd, MD, Scott Jewell, PhD, Mary Derome, MS, Jen Troups, Daniel Auclair, PhD, Sagar Lonial, MD, David Craig, PhD, Jonathan J Keats, PhD, John David Carpten, PhD

Blood (2015) 126 (23): 2973.

https://doi.org/10.1182/blood.V126.23.2973.2973

Published: 2015

Journal Articles

Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study

Blood (2015) 126 (23): 722.

https://doi.org/10.1182/blood.V126.23.722.722

Published: 2015

Journal Articles

A Second Generation, Multiple Myeloma-Specific, Targeted Sequencing Platform for Detecting Translocations, Copy Number Alterations, and Single Nucleotide Variants

Brian S White, PhD, Irena Lanc, PhD, Daniel Auclair, PhD, Robert Fulton, PhD, Mark A Fiala, BS, CCRP, Justin King, Gregory Ahmann, BS, Mary Derome, MS, Elaine R Mardis, PhD, Joan Levy, PhD, Ravi Vij, MD MBA, John F. DiPersio, MD PhD, Michael Tomasson, MD

Blood (2015) 126 (23): 4207.

https://doi.org/10.1182/blood.V126.23.4207.4207

Published: 2015

Journal Articles

Investigation of Mechanisms of Response in Multiple Myeloma Via Bayesian Causal Inference: An Early Analysis of the Commpass Study Data

Fred Gruber, PhD, Boris Hayete, PhD, Jonathan J Keats, PhD, Kyle McBride, MS, Runge Karl, PhD, Mary Derome, MS, Sagar Lonial, MD, Iya Khalil, PhD, Daniel Auclair, PhD

Blood (2015) 126 (23): 1794.

https://doi.org/10.1182/blood.V126.23.1794.1794

Published: 2015

Journal Articles

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Blood (2014) 124 (21): 722.

https://doi.org/10.1182/blood.V124.21.722.722

Published: 2014

NARROW

Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project

Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma

Aberrant a-to-I RNA Editing and Prognostic Impact of Adar in Multiple Myeloma Patients with 1q Amplification

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Prognostic Implication of Somatic Mutations By Next Generation Sequencing: An Analysis from the Mmrf Commpass Study in Newly Diagnosed Multiple Myeloma Patients

Bayesian Network Models of Multiple Myeloma: Drivers of High Risk and Durable Response

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

A Comparison of Clinical FISH and Sequencing Based FISH Estimates in Multiple Myeloma: An Mmrf Commpass Analysis

Network Modeling Reveals CDC42BPA and CLEC11A As Novel Driver Genes of t(4; 14) Multiple Myeloma

In-Depth Molecular Profiling of Multiple Myeloma in African Americans

Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study

A Second Generation, Multiple Myeloma-Specific, Targeted Sequencing Platform for Detecting Translocations, Copy Number Alterations, and Single Nucleotide Variants

Investigation of Mechanisms of Response in Multiple Myeloma Via Bayesian Causal Inference: An Early Analysis of the Commpass Study Data

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only